This preliminary program is subject to change.

PAT Applications in Pharmaceuticals and Biopharmaceuticals


Description:
Applications of process analytical technology to unit operations and overall process design/development will be discussed. Examples of utilizing PAT for feedback control and process automation are a focus as well.

Sponsor:
Pharmaceuticals


Chair:
James Marek
Research Investigator
Abbott Laboratories
GPRD Process Engineering
1401 Sheridan Rd., MS R13-2
North Chicago, IL 60064-6292
Phone Number: 847-935-6770
Email: james.marek@abbott.com

Co-Chair:
Gregory M. Troup

Papers:
PAT Applied to Understanding and Controlling the Removal of Dissolved Gases From Processes in API Development
Mark A. LaPack, Eli Lilly and Company; Christopher L. Burcham, Eli Lilly and Company; Shekhar K. Viswanath, Eli Lilly and Company; Joseph Martinelli, Eli Lilly and Company
Model-Based Versus Calibration-Based Application of in Situ ATR-FTIR and Raman Spectroscopy
Jeroen Cornel, Institute of Process Engineering, ETH Zurich; Marco Mazzotti, Institute of Process Engineering, ETH Zurich
Development of Process Analytical Technology (PAT) Methods for Online Control of Glycosylation Profiles During Monoclonal Antibody (MAb) Production
Melissa St. Amand, University of Delaware; Peter G. Millili, University of Delaware; Meghan McCabe, University of Delaware; Mark Stitz, University of Delaware; Babatunde A. Ogunnaike, University of Delaware
Endoscopy and External Bulk Video Imaging Based Nucleation Detection, Metastable Zone Identification and Crystallization Monitoring for Caffeine and Palm Oil Crystallization
Levente L. Simon, ETH Zurich; Zoltan K. Nagy, Loughborough University; Konrad Hungerbuehler, Swiss Federal Institute of Technology Zurich
Exceptional Events Management for Continuous Pharmaceutical Manufacturing: Application & Integration Into POPE and DeltaV
Intan Munirah Hamdan, Purdue University; Gintaras V. Reklaitis, Purdue University; Venkat Venkatasubramanian, Purdue University
See more of this Group/Topical: Food, Pharmaceutical & Bioengineering Division